Procalcitonin-Guided Antibiotics for Lower Respiratory Tract Infection – The ProACT Trail
Procalcitonin has proven to be a great marker for guiding antibiotics treatment in patients with concern for lower respiratory tract infections. However, it's not yet established how much does clinicians adhere to using the antibiotic therapy based on procalcitonin results. The ProACT trial recently got published in NEJM. It showed that despite it's usefulness, clinicians still base their antibiotic use on clinical suspicion. Take a look at our visual abstract for the findings.
[TheChamp-Sharing style="background-color:#FFFFFF;"]Want to read more posts?